After a buoyant week, investors are expected to start the week with caution. With a lack of overarching global cues, volatility may persist. The rising number of cases of Covid in China and citizens retaliating against the Zero-Covid policy will be a topic that investors will keep an eye on. Zydus Lifesciences has received approval […]